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httpIntroduction: Primary infection of a bare metal stent is a rare condition, associated with signiﬁcant morbidity and
mortality. Deﬁnitive treatment includes stent removal and arterial reconstruction.
Report: This study details a common iliac stent infection after re-intervention for iliac stent occlusion,
complicated by pseudoaneurysm formation and septic embolisation. Potential risk factors for stent infection
were identiﬁed. An open surgical resection of the affected artery along with all stent material was performed,
followed by reconstruction with autologous interposition superﬁcial femoral vein. There were no complications
and no recurrent infection at 6 months follow-up.
Conclusion: Although rare, bare metal stent infection may occur, and a high index of suspicion is required. Stent
surgical removal and arterial in situ reconstruction with autologous femoral vein proved to be a deﬁnitive
procedure with no mid-term morbidity.
 2017 The Author(s). Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Bare metal stents are routinely used for treatment of
arterial occlusive disease in many territories. Primary iliac
stenting is a standard treatment for atherosclerotic disease
of iliac arteries, widely used and associated with acceptable
long-term patency rates.
Stent infection is a rare complication, particularly with
the use of bare metal stents compared with covered
stents.1 This complication is associated with signiﬁcant
morbidity (17.2e73.5%) and mortality (32.5%).2
This study reports a case of an iliac stent infection after
treatment of in-stent restenosis, treated successfully by
resection of the affected arterial segment and superﬁcial
femoral vein interposition. Potential risk factors are identiﬁed.CASE REPORT
A 57 year old male, with a past medical history of hyper-
tension, dyslipidaemia, current smoking habit, and periph-
eral arterial disease, was referred with Rutherford
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://dx.doi.org/10.1016/j.ejvssr.2017.01.001presented with disabling left buttock and lower limb
claudication.
Chronic total occlusion of the left common iliac artery was
observed. Endovascular treatment was performed through
percutaneous ipsilateral femoral access and a balloon
expandable stent (960mm; Assurant CobaltMedtronic, Inc)
was implanted.The patency of the iliac segment was restored
without any complications. A satisfactory clinical result was
achieved with resolution of claudication.
The patient remained asymptomatic for 4 years, at which
time his claudication recurred. An iliac stent occlusion was
identiﬁed and a secondary endovascular intervention was
planned in the angiography suite. A drug coat coated balloon
angioplasty of the iliac stent occlusion was performed via
ipsilateral retrograde femoral access, using an In.Pact Paciﬁc
(Medtronic, Inc) 780mm balloon. The control angiogram
showed a suboptimal result with residual stenosis and a
second 957mm balloon expandable stent (BeSmooth Pe-
ripheral Stent, Bentley InnoMed GmbH) was implanted.
Thirteen days after this second intervention the patient
developed fever associated with collapse and left lower
limb tenderness and pain. On physical examination there
were skin signs of distal embolisation in the left lower limb
(Fig. 1), extending to skin ulceration in some areas. The
dorsalis pedis pulse was palpable.
Laboratory tests revealed a signiﬁcant rise in inﬂamma-
tory markers, with a C-reactive protein of 327mg/L,
neutrophilic leukocytosis (18.7103/mL leukocytes and
15.3103/mL neutrophils), and D-dimers of 15815ng/mL.
Figure 1. Skin lesions of septic embolism in the left lower limb (A: left foot; B: left thigh; C: left leg calf region).
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Staphylococcus aureus. Echocardiography revealed no signs
of endocarditis and no other organ involvement.
Computed tomography angiography showed a left com-
mon iliac artery pseudoaneurysm related to the stent im-
plantation site, associated with peri-stent soft tissue
inﬂammation (Fig. 2).
The presence of an arterial pseudoaneurysm in the iliac
stent position, associated with ipsilateral septic embolisa-
tion and positive blood cultures, conﬁrmed the diagnosis of
iliac stent infection and surgical treatment was planned.
The patient started on broad antibiotic therapy with
piperacillin/tazobactam (4g/500mg 8 hourly) and vanco-
mycin (1gr 12 hourly) subsequently adjusted to ciproﬂoxa-
cin (750mg 12 hourly) based on the antimicrobial sensitivity
testing.
Resection of the implanted material and affected arterial
segment and in situ reconstruction with autologous venous
conduit was planned. The right superﬁcial femoral vein was
harvested (Fig. 3) and transperitoneal aorto-iliac exposure
was performed through a midline laparotomy. The left
common iliac artery showed signs of infection. After sys-
temic heparinisation with 5000 IU heparin, the infrarenal
aorta and iliac arteries were clamped and the affected
segment was resected along with all implanted material.
After thorough cleansing of the surrounding tissue with
saline solution, an interposition vein graft was constructed
restoring patency of the left iliac segment (Fig. 4).
The post-operative recovery was uncomplicated and the
patient was discharged 15 days after surgery with
decreased inﬂammatory markers (8.0103/mL leukocytes
and a CRP of 52.4mg/L). The patient remained on antibiotic
therapy with ciproﬂoxacin (750mg; q12hr) for 14 days after
surgery. Microbiology culture of the stent was negative,
probably because of the ongoing treatment with intrave-
nous antibiotics.The patient remains asymptomatic after 6 months, with
no complaints of claudication, leg pain, or skin lesions, and
with no oedema of the right leg. There is no evidence of
recurrent infection.DISCUSSION
Vascular stent infection can be associated with signiﬁcant
morbidity (17.2e75.3%),2 and its deﬁnitive treatment may
require a complex invasive surgical procedure, particularly
in intra-abdominal and intra-thoracic positions which are
associated with a mortality rate of 20e50%.3
In 2013 Bosman et al.2 reviewed all reports of intravas-
cular bare metal stent infections, and identiﬁed 77 cases (29
coronary and 48 non-coronary). Common iliac artery stent
infections represented 23.4% of the overall described cases.
In the non-coronary group, the iliac segment was the ter-
ritory most frequently involved in stent infection, followed
by the femoral artery and the renal artery.2
Most reported cases developed early, within 2 weeks of
stent implantation.3,4 A break in sterile technique is sug-
gested as the most likely cause in these early stent in-
fections. This was also the case in the patient described
here, in whom the temporal association between implant
and onset of symptoms suggests procedural contamination
as the aetiology. In 25% of cases the infection occurs at a
later stage, months to years after stent placement.3 The
most prevalent agent isolated is Staphylococcus aureus,
responsible for 83% of stent infections.3,5
Clinical presentation of a stent infection may include
progressive arterial destruction with disruption and hae-
morrhage, pseudoaneurysm formation, septic embolisation,
and stent thrombosis.2,4e7 Pseudoaneurysm arterial
degeneration is the most common radiological sign, found
in 77.9% of stent infection cases.2 In the present case, the
stent remained patent, but there were signs of septic
Figure 2. Computed tomography angiography showing the left common iliac artery pseudoaneurysm related to the stent implantation site
(white arrow); axial and sagittal views (A, B); three dimensional volume rendered reconstruction of the computed tomography angiogram
(C, D).
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pseudoaneurysm involving the common iliac stent was
present.
The rarity and non-speciﬁc clinical manifestations mean
that there is a delay in the diagnosis in 50.7% of cases.2 A
high level of suspicion is mandatory for a timely diagnosis.
Stent infection should be considered in the differential
diagnosis of bacteraemia and fever in a patient with a his-
tory of stent implantation, especially if within 2e4 weeks of
the procedure.2Figure 3. Right superﬁcial femoral vein harvest.A review of reported cases conducted by Hogg et al.6
identiﬁed risk factors for stent infection. In the present
case there were several potential risk factors: it followed a
second intervention, prophylactic antibiotics were not
administered, and a drug coated balloon was used prior to
the second stent implantation. Another potential risk factor
could be that the procedure was performed in the angi-
ography suite, which is a less aseptic environment
compared with the operating theatre.
Neointimal formation and the incorporation of the stent
in the arterial wall is reported as a protective measure
against stent infection.4,7 Inhibition of neointimal hyper-
plasia, promoted by drug-eluting stents, is underlined as a
risk factor for early infections.2 In the case described here,
the use of a drug coated balloon before implantation of the
second stent could have played a role in the onset of the
infection.
Open surgical repair is the preferred treatment option
whenever possible. Other options include conservative
therapy with antibiotics or an endovascular approach, both
associated with considerable mortality rates (50e75%).2,5
The deﬁnitive treatment may include stent removal and
vascular reconstruction. The use of autologous superﬁcial
femoral vein for in situ arterial reconstruction is a valid
option with recognised advantages especially in an infected
ﬁeld.5,8 The femoral vein is a large calibre autogenous
conduit with approximately the same diameter as the iliac
artery and is robust, resisting recurrent infection better
than prosthetic conduits or thin walled veins such as the
Figure 4. Surgery procedure images. (A) Resection of the segment of common iliac artery with the implanted stents at the aortic bifur-
cation (stent struts visible). (B) Aortic bifurcation after excision of the affected iliac segment (IVC, inferior vena cava). (C) Proximal
anastomosis of the interposition superﬁcial femoral vein conduit. (D) Distal anastomosis. (E) Iliac arterial wall and stents explanted.
Iliac Artery Reconstruction after Stent Infection 31saphenous vein. Superﬁcial vein harvest however, adds
complexity and time to the procedure, and may be associ-
ated with venous morbidity symptoms, such as leg oedema
in less than one third of the cases (11e15.2%).9,10 Allografts
have also been used successfully as conduits, but can have
limited availability and cost, and the durability seems infe-
rior to autologous vein.9 As an alternative, ligation and
extra-anatomical femoro-femoral bypass has been
described, but this has poor long-term results,9 with the
disadvantages of the risk of stump blowout and lower
patency compared with in situ reconstruction.CONCLUSION
Bare metal stent infection is a rare but serious condition
that can result in signiﬁcant morbidity. Resection of infected
tissue and implanted material, and in situ reconstruction
using autologous superﬁcial femoral vein provides an
effective and durable treatment. Identiﬁcation of risk fac-
tors such as re-intervention and use of local antimitotic
drugs, use of antibiotic prophylaxis, and strict compliance
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